MetaCap

Harmony Biosciences Insider Trades

NASDAQ: HRMYHealthcareBiotechnologyUSD

40.28+0.68 (+1.72%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
13 · $5.95M
Shares bought / sold
0 / 146.47K
Net activity
Net selling $6.0 million

Harmony Biosciences insider activity

Over the last 12 months, Harmony Biosciences insiders reported 43 transactions on SEC Form 4: 0 open-market purchases and 13 sales. Insiders bought $0 and sold $6.0 million worth of stock, for net insider selling of $6.0 million. The largest seller was Budur Kumar, with $3.1 million in reported sales.

The most recent filing shows Budur Kumar (CHIEF MEDICAL OFFICER) reporting a transaction in 10,406 shares at $30.69 on Sep 18, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put HRMY's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

HRMY insider transactions

Harmony Biosciences insider transactions
DateInsiderTypeSharesValueFiling
Sep 18, 2026Budur KumarCHIEF MEDICAL OFFICERSale35,852$1.54MForm 4
Sep 18, 2026Budur KumarCHIEF MEDICAL OFFICEROption exercise25,446$770.25KForm 4
Sep 18, 2026Budur KumarCHIEF MEDICAL OFFICEROption exercise10,406$319.36KForm 4
Sep 17, 2026Budur KumarCHIEF MEDICAL OFFICERSale800$34.40KForm 4
Sep 17, 2026Budur KumarCHIEF MEDICAL OFFICEROption exercise400$12.11KForm 4
Sep 17, 2026Budur KumarCHIEF MEDICAL OFFICEROption exercise400$12.28KForm 4
Sep 16, 2026Budur KumarCHIEF MEDICAL OFFICERSale1,800$77.43KForm 4
Sep 16, 2026Budur KumarCHIEF MEDICAL OFFICEROption exercise900$27.24KForm 4
Sep 16, 2026Budur KumarCHIEF MEDICAL OFFICEROption exercise900$27.62KForm 4
Sep 8, 2026Budur KumarCHIEF MEDICAL OFFICERSale22,954$989.35KForm 4
Sep 8, 2026Budur KumarCHIEF MEDICAL OFFICEROption exercise10,754$325.52KForm 4
Sep 8, 2026Budur KumarCHIEF MEDICAL OFFICEROption exercise12,200$374.42KForm 4
Sep 8, 2026Budur KumarCHIEF MEDICAL OFFICERSale1,000$42.79KForm 4
Sep 8, 2026Budur KumarCHIEF MEDICAL OFFICERSale4,500$190.11KForm 4
Sep 4, 2026Budur KumarCHIEF MEDICAL OFFICERSale5,500$230.91KForm 4
May 1, 2026Budur KumarCHIEF MEDICAL OFFICERTax withholding8,882$282.71KForm 4
May 1, 2026Budur KumarCHIEF MEDICAL OFFICEROption exercise18,750—Form 4
Apr 7, 2026Zaeske Adam H.CHIEF COMMERCIAL OFFICERTax withholding3,173$87.64KForm 4
Apr 7, 2026Zaeske Adam H.CHIEF COMMERCIAL OFFICEROption exercise7,500—Form 4
Jan 26, 2026Kapadia SandipCHIEF FINANCIAL OFFICERSale3,746$139.17KForm 4
Jan 25, 2026Kapadia SandipCHIEF FINANCIAL OFFICERTax withholding2,553$94.00KForm 4
Jan 25, 2026Kapadia SandipCHIEF FINANCIAL OFFICEROption exercise4,725—Form 4
Jan 25, 2026Dayno Jeffrey M.PRESIDENT, CEOTax withholding5,654$208.18KForm 4
Jan 25, 2026Dayno Jeffrey M.PRESIDENT, CEOOption exercise13,000—Form 4
Jan 25, 2026Budur KumarCHIEF MEDICAL OFFICERTax withholding1,372$50.52KForm 4
Jan 25, 2026Budur KumarCHIEF MEDICAL OFFICEROption exercise2,662—Form 4
Jan 25, 2026Serafin AndrewCHIEF STRATEGY OFFICERTax withholding1,126$41.46KForm 4
Jan 25, 2026Serafin AndrewCHIEF STRATEGY OFFICEROption exercise2,600—Form 4
Jan 24, 2026Kapadia SandipCHIEF FINANCIAL OFFICERTax withholding2,239$82.44KForm 4
Jan 24, 2026Kapadia SandipCHIEF FINANCIAL OFFICEROption exercise3,813—Form 4
Jan 24, 2026Dayno Jeffrey M.PRESIDENT, CEOTax withholding4,785$176.18KForm 4
Jan 24, 2026Dayno Jeffrey M.PRESIDENT, CEOOption exercise10,500—Form 4
Jan 24, 2026Budur KumarCHIEF MEDICAL OFFICERTax withholding1,153$42.45KForm 4
Jan 24, 2026Budur KumarCHIEF MEDICAL OFFICEROption exercise2,188—Form 4
Jan 24, 2026Serafin AndrewCHIEF STRATEGY OFFICERTax withholding1,116$41.09KForm 4
Jan 24, 2026Serafin AndrewCHIEF STRATEGY OFFICEROption exercise2,500—Form 4
Jan 15, 2026Kapadia SandipCHIEF FINANCIAL OFFICERSale20,961$752.83KForm 4
Dec 12, 2025Dayno Jeffrey M.PRESIDENT, CEOSale5,933$237.96KForm 4
Dec 12, 2025Dayno Jeffrey M.PRESIDENT, CEOSale20,000$802.15KForm 4
Dec 12, 2025Dayno Jeffrey M.PRESIDENT, CEOOption exercise20,000$164.40KForm 4
Dec 5, 2025Kapadia SandipCHIEF FINANCIAL OFFICERSale20,000$790.90KForm 4
Dec 5, 2025Kapadia SandipCHIEF FINANCIAL OFFICEROption exercise20,000$580.60KForm 4
Nov 21, 2025Kapadia SandipCHIEF FINANCIAL OFFICERSale3,427$119.94KForm 4
Sep 30, 2025Kapadia SandipCHIEF FINANCIAL OFFICERTax withholding24,039$662.51KForm 4
Sep 30, 2025Kapadia SandipCHIEF FINANCIAL OFFICEROption exercise45,000—Form 4
Aug 28, 2025Valor IV Pharma Holdings, LLC & Valor Management L.P. & Valor Equity Capital IV LLC & Valor Equity Associates IV L.P. & VALOR EQUITY PARTNERS IV L.P. & VALOR EQUITY PARTNERS IV-A L.P. & VALOR EQUITY PARTNERS IV-B L.P. & Gracias Antonio J. & Sabater Juan A.10% Ownerother6,618,033—Form 4
Aug 15, 2025Kapadia SandipCHIEF FINANCIAL OFFICERSale21,573$787.38KForm 4
May 1, 2025Budur KumarCHIEF MEDICAL OFFICERTax withholding8,869$264.83KForm 4
May 1, 2025Budur KumarCHIEF MEDICAL OFFICEROption exercise18,750—Form 4
Apr 1, 2025Kapadia SandipCHIEF FINANCIAL OFFICERSale740$24.51KForm 4
Apr 1, 2025Kapadia SandipCHIEF FINANCIAL OFFICERSale6,247$202.88KForm 4
Mar 29, 2025Kapadia SandipCHIEF FINANCIAL OFFICERTax withholding8,014$265.98KForm 4
Mar 29, 2025Kapadia SandipCHIEF FINANCIAL OFFICEROption exercise15,000—Form 4
Mar 3, 2025Dierks JeffreyCHIEF COMMERCIAL OFFICERSale500$16.62KForm 4
Mar 3, 2025Dierks JeffreyCHIEF COMMERCIAL OFFICERSale4,369$142.47KForm 4
Mar 3, 2025Dierks JeffreyCHIEF COMMERCIAL OFFICEROption exercise4,869$40.02KForm 4
Jan 24, 2025Budur KumarCHIEF MEDICAL OFFICERTax withholding1,151$43.75KForm 4
Jan 24, 2025Budur KumarCHIEF MEDICAL OFFICEROption exercise2,187—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related